rs703258

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000623461.3(VCL):​n.7588T>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.733 in 152,428 control chromosomes in the GnomAD database, including 41,710 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 41618 hom., cov: 31)
Exomes 𝑓: 0.66 ( 92 hom. )

Consequence

VCL
ENST00000623461.3 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.26

Publications

14 publications found
Variant links:
Genes affected
VCL (HGNC:12665): (vinculin) Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
VCL Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1W
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy 15
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-74119753-T-A is Benign according to our data. Variant chr10-74119753-T-A is described in ClinVar as Benign. ClinVar VariationId is 300815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.78 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCLNM_014000.3 linkc.*1584T>A 3_prime_UTR_variant Exon 22 of 22 ENST00000211998.10 NP_054706.1 P18206-1V9HWK2B3KXA2
VCLNM_003373.4 linkc.*1584T>A 3_prime_UTR_variant Exon 21 of 21 NP_003364.1 P18206-2A0A024QZN4B3KXA2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCLENST00000623461.3 linkn.7588T>A non_coding_transcript_exon_variant Exon 23 of 23 1
VCLENST00000211998.10 linkc.*1584T>A 3_prime_UTR_variant Exon 22 of 22 1 NM_014000.3 ENSP00000211998.5 P18206-1
VCLENST00000372755.7 linkc.*1584T>A 3_prime_UTR_variant Exon 21 of 21 1 ENSP00000361841.3 P18206-2

Frequencies

GnomAD3 genomes
AF:
0.733
AC:
111398
AN:
151890
Hom.:
41585
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.787
Gnomad AMI
AF:
0.694
Gnomad AMR
AF:
0.706
Gnomad ASJ
AF:
0.857
Gnomad EAS
AF:
0.394
Gnomad SAS
AF:
0.536
Gnomad FIN
AF:
0.664
Gnomad MID
AF:
0.867
Gnomad NFE
AF:
0.750
Gnomad OTH
AF:
0.778
GnomAD4 exome
AF:
0.662
AC:
278
AN:
420
Hom.:
92
Cov.:
0
AF XY:
0.684
AC XY:
171
AN XY:
250
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.658
AC:
271
AN:
412
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AF:
0.833
AC:
5
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.733
AC:
111483
AN:
152008
Hom.:
41618
Cov.:
31
AF XY:
0.725
AC XY:
53820
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.787
AC:
32624
AN:
41444
American (AMR)
AF:
0.705
AC:
10765
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
2976
AN:
3472
East Asian (EAS)
AF:
0.394
AC:
2036
AN:
5164
South Asian (SAS)
AF:
0.537
AC:
2590
AN:
4824
European-Finnish (FIN)
AF:
0.664
AC:
6993
AN:
10538
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.750
AC:
50992
AN:
67980
Other (OTH)
AF:
0.771
AC:
1624
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1473
2946
4420
5893
7366
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.745
Hom.:
5267
Bravo
AF:
0.735
Asia WGS
AF:
0.488
AC:
1701
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dilated cardiomyopathy 1W Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.4
DANN
Benign
0.44
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs703258; hg19: chr10-75879511; COSMIC: COSV53011652; COSMIC: COSV53011652; API